Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection
Sinjini Patra, Shivam Saxena, Nilanjan Sahu, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 13, Iss. 4, pp. 1138-1156
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Post-COVID-19 acute sarcopenia: physiopathology and management
Karolina Piotrowicz, Jerzy Gąsowski, Jean‐Pierre Michel, et al.
Aging Clinical and Experimental Research (2021) Vol. 33, Iss. 10, pp. 2887-2898
Open Access | Times Cited: 221
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 174-192
Open Access | Times Cited: 97
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
В. Т. Ивашкин, В. В. Фомин, Sergey Moiseev, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 15, Iss. 3, pp. 460-468
Open Access | Times Cited: 49
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4942-4942
Open Access | Times Cited: 48
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
Virna Margarita Martín Giménez, Javier Modrego, Dulcenombre Gómez‐Garré, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12249-12249
Open Access | Times Cited: 19
Probing the functional and therapeutic properties of postbiotics in relation to their industrial application
Abrar Asif, Muhammad Afzaal, Hina Shahid, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 8, pp. 4472-4484
Open Access | Times Cited: 17
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome
Denise Battaglini, Chiara Robba, Andrea Fedele, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19
Sophie Tomkinson, Cloe Triscott, Emily Schenk, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 928-928
Open Access | Times Cited: 14
The Association Between the Gut Microbiome and COVID-19 Severity: The Potential Role of TMAO Produced by the Gut Microbiome
Milad Shahini Shams Abadi, Rozita Khodashahi, Mohsen Aliakbarian, et al.
Archives of Clinical Infectious Diseases (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 5
In Silico Analysis of Bacteriocins from Lactic Acid Bacteria Against SARS-CoV-2
İsmail Erol, Seyfullah Kotil, Özkan Fidan, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 15, Iss. 1, pp. 17-29
Open Access | Times Cited: 31
Effects of yogurt containing probiotics on respiratory virus infections: Influenza H1N1 and SARS-CoV-2
Ha-Young Jeon, Kyeongsoon Kim, Sokho Kim
Journal of Dairy Science (2023) Vol. 106, Iss. 3, pp. 1549-1561
Open Access | Times Cited: 12
Complete genome sequence, metabolic profiling and functional studies reveal Ligilactobacillus salivarius LS-ARS2 is a promising biofilm-forming probiotic with significant antioxidant, antibacterial, and antibiofilm potential
Sinjini Patra, Biswaranjan Pradhan, Anasuya Roychowdhury
Frontiers in Microbiology (2025) Vol. 16
Open Access
The Exposome and Immune Health in Times of the COVID-19 Pandemic
Javier S. Morales, Pedro L. Valenzuela, Adrián Castillo‐García, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 24-24
Open Access | Times Cited: 21
Heat‐killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome
Hongxia Fan, Shuo Sheng, Daidi Li, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Potential of macronutrients and probiotics to boost immunity in patients with SARS-COV-2: a narrative review
Afrouz Mardi, Aziz Kamran, Farhad Pourfarzi, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 8
Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases
Mahmoud Youssef, Hanaa Y. Ahmed, Abel Wend‐Soo Zongo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11290-11290
Open Access | Times Cited: 18
Vitamin K in COVID-19—Potential Anti-COVID-19 Properties of Fermented Milk Fortified with Bee Honey as a Natural Source of Vitamin K and Probiotics
Amira Mohammed Ali, Hiroshi Kunugi, Hend A. Abdelmageed, et al.
Fermentation (2021) Vol. 7, Iss. 4, pp. 202-202
Open Access | Times Cited: 16
Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease
Giuseppe Alloatti, Cláudia Penna, Stefano Comità, et al.
Vascular Pharmacology (2022) Vol. 145, pp. 107001-107001
Closed Access | Times Cited: 12
Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review
Manoj Kumar Sarangi, Sasmita Padhi, Lakshamanbhai Dungarbhai Patel, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103764-103764
Open Access | Times Cited: 11
Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era
Osamu Kanauchi, Zhao Xuan Low, Kenta Jounai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Identification of cardiomyopathy-related core genes through human metabolic networks and expression data
Zherou Rong, Hongwei Chen, Zihan Zhang, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Dietary supplements and nutraceuticals in the recovery of COVID-19: A systematic review and meta-analysis
Fahad Aldhafiri
Nutrition Clinique et Métabolisme (2022) Vol. 36, Iss. 3, pp. 173-181
Closed Access | Times Cited: 4
Efficacy of nutraceuticals (probiotics or prebiotics or synbiotics) in the prevention or treatment of COVID -19: a systematic review and meta-analysis
Anju Pradhan Sinha, Mahalaqua Nazli Khatib, Abhay Gaidhane, et al.
Cogent Food & Agriculture (2024) Vol. 10, Iss. 1
Open Access
Antiviral Activity of Probiotics in the Prophylaxis and Therapy of Respiratory Infections Associated with Coronavirus (COVID-19): Meta-analysis of Randomized Controlled Trials
Slimane Chawki Mokadem, Mostefa Naimi, Omar Alami
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top